Can neoadjuvant radiochemotherapy improve the results of multivisceral resection in advanced rectal carcinoma (cT4a)

Colorectal Disease

Volumn 5, Issue 5, 2003, Pages 436-441

  Göhl, Jonas ^a   Merkel, S ^a   Rodel C ^a   Hohenberger, W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Advanced tumours; Locoregional recurrence; Multivisceral resection; Neoadjuvant radiochemotherapy; Rectal carcinoma; Survival; T4a

Indexed keywords

FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER INFILTRATION; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GASTROINTESTINAL TOXICITY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOMA; RECTUM RESECTION; REGRESSION ANALYSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0042328221     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.2003.00525.x     Document Type: Article

References (22)

1. Farouk R, Nelson H, Gunderson LL. Aggressive multimodality treatment for locally advanced irresectable rectal cancer. Br J Surg 1997; 84: 741-9.
2. Meterissian SH, Skibber JM, Giacco GG et al. Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. Surgery 1997; 121: 479-87.
3. Gastrointestinal Tumor Study Group (GITSG). Survival after post-operative combination treatment of rectal cancer. N Engl J Med 1986; 315: 1294-5.
4. Krook JE, Moertel CG, Gunderson LL et al. Effective surgical adjuvant therapy for high-risk rectal cancer. N Engl J Med 1995; 324: 709-15.
5. O'Conell MJ, Martenson JA, Wieind HS et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation after curative surgery. N Engl J Med 1994; 331: 502-7.
6. Minsky BD, Cohen AM, Kemeny N et al. Enhancement of radiation-in-duced downstaging of rectal cancer by 5-FU and high-dose leucovorin chemotherapy. J Clin Oncol 1992; 10: 79-84.
7. Minsky BD, Cohen AM, Kemeny N et al. The efficacy of preoperative 5-Fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer 1993; 71: 3486-92.
8. Sobin LH, Wittekind Ch, eds (2002 6th edition) TNM Classification of Malignant Tumors. UICC John Wiley & Sons, New York.
9. Wittekind Ch, Henson DE, Huttler RVP, Sobin LH, eds (2001) TNM-Supplement. UICC John Willey & Sons, New York.
10. Willeke F, Von Gerstenbergk-Helldorf B. Significance of surgery in the multimodality treatment of rectal cancer. Onkologie 2002; 25: 324-32.
11. Theodoropoulos G, Wise WE, Padmanabhan A et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free. Dis Colon Rectum 2002; 45: 895-903.
12. Rau B, Hohenberger P, Gellermann J et al. T4 rectal carcinoma. Surgical and multimodal therapy. Chirurg 2002; 73: 147-53.
13. Mehta VK, Poen J, Ford J et al. Radiotherapy, concomitant protracted-venous-infusion 5-Fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis Colon Rectum 2001; 44: 52-8.
14. Schaffer M, Thoma M, Wilkowski R, Schaffer P, Duhmke E. Radio-chemotherapy as a pre-operative treatment for advanced rectal cancer. Evaluation of down-staging and morbidity. Onkologie 2002; 25: 352-6.
15. Janjan NA, Crane CN, Feig BW et al. Prospective trial of pre-operative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000; 47: 713-8.
16. Onaitis MW, Noone RB, Hartwig M et al. Neoadjuvant chemoradiation for rectal cancer analysis of clinical outcomes from a 13-year institutional experience. Ann Surg 2001; 233: 778-85.
17. Kuchenmeister U, Kirchner R, Mellert J et al. First results of neoadjuvant simultaneous radiochemotherapy in advanced rectal carcinoma. Strahlenther Onkol 2000; 176: 560-6.
18. Tjandra JJ, Reading DM, McLachlan SA et al. Phase II clinical trial of pre-operative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results. Dis Colon Rectum 2001; 44: 1113-22.
19. Zirngibl H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 1990; 33: 610-4.
20. Rodel C, Grabenbauer GG, Schick C, Papadopoulos T, Hohenberger W, Sauer R. Pre-operative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer. Strahlenther Onkol 2000; 176: 161-7.
21. Sanfilippo NJ, Crane CH, Skibber J et al. T4 rectal cancer treated with pre-operative chemoradiation to the posterior pelvis followed by multivisceral resection patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys 2001; 51: 176-83.
22. Videtic GM, Fisher BJ, Perera FE et al. Pre-operative radiation with concurrent 5-fluorouracil continuos infusion for locally advanced unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1998; 42: 319-24.